Studying Non Alcoholic Fatty Liver Disease and Liver Fibrosis Among Systemic Lupus Erythematosus Patients at Assiut University Hospital

ConditionNAFLD - Nonalcoholic Fatty Liver Disease

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18-75

SponsorAssiut University

About this trial

Aim of the study :-

1. to estimate prevalence of non alcoholic fatty liver disease and liver fibrosis among Systemic lupus erythematosus patients 2. to determine risk factors in SLE patients contributing to NAFLD and liver fibrosis

Eligibility criteria

Qualifiers

Adult patients aged 18 years old ,Both sex male and female, diagnosed with SLE

Disqualifiers

Age below 18 years old

patients with hepatitis b virus (HBV), hepatitis c virus (HCV) or cirrhosis

malignancy, cardiac disease,

patients on dialysis.

Trial design

Treatments tested in this trial

Fibroscan

Treatment groups

No treatment groups listed

Locations

This trial has no locations

Sponsors and collaborators

Assiut University

Lead sponsor

Source ClinicalTrials.gov